How to Help Your Patients Find Cefprozil in Stock: A Provider's Guide

Your Patient Needs Cefprozil — And Their Pharmacy Doesn't Have It

You've prescribed Cefprozil for a straightforward bacterial infection. An hour later, your front desk gets a call: the patient's pharmacy doesn't have it. Can you send it somewhere else? Can you change the antibiotic? The patient is frustrated, your staff is interrupted, and a simple prescription has become a 20-minute workflow disruption.

This scenario has become increasingly common in 2026. Cefprozil supply — particularly the oral suspension — remains inconsistent across the country. But there are concrete steps you and your team can take to minimize these disruptions and keep your patients on track.

Current Cefprozil Availability

Here's where things stand as of early 2026:

• 250 mg and 500 mg tablets: Generally available at most pharmacies, with occasional regional spot shortages
• 125 mg/5 mL and 250 mg/5 mL oral suspension: Intermittently unavailable — this is where most patient complaints originate

The disparity between tablet and suspension availability is significant. Adult patients can usually get their prescriptions filled without much trouble. Pediatric patients needing the liquid formulation face a much harder search.

Why Patients Can't Find It

Understanding the supply dynamics helps frame your response:

• Concentrated manufacturing: Only a handful of generic manufacturers produce Cefprozil. A production issue at one plant can remove a significant percentage of national supply.
• Uneven distribution: Pharmacies source from different wholesalers, creating a patchwork where some locations have stock and others don't — even in the same city.
• Cascading demand: When other cephalosporins or Amoxicillin are short, prescribers shift to Cefprozil, creating demand spikes that outpace supply.
• Suspension-specific challenges: Liquid formulations are more complex to manufacture and have shorter shelf lives once reconstituted (14 days), making inventory management harder for both manufacturers and pharmacies.

What Providers Can Do: 5 Practical Steps

Step 1: Check Availability Before Prescribing

The single most effective step you can take is verifying that Cefprozil is available at your patient's pharmacy before sending the prescription. Medfinder for Providers allows you to search real-time pharmacy inventory by medication and location in seconds.

Build this into your prescribing workflow: before clicking "send" in your EHR, have your MA or nurse verify availability. This prevents the callback-and-rewrite cycle that wastes everyone's time.

Step 2: Have 2–3 Alternatives Ready

When Cefprozil isn't available, you need to pivot quickly. Keep these alternatives in your mental (or EHR) shortlist:

• Cefuroxime (Ceftin): Closest therapeutic match. Second-generation cephalosporin, similar spectrum. 250–500 mg BID for adults; suspension available for pediatrics. Take with food.
• Amoxicillin/Clavulanate (Augmentin): Broader gram-negative coverage. Good for otitis media and sinusitis, especially with treatment failure. Higher GI side effect rate.
• Cephalexin (Keflex): First-gen cephalosporin. Best for pharyngitis and skin infections. Less ideal for sinusitis/otitis due to limited H. influenzae coverage. Very cheap and widely available.
• Azithromycin (Zithromax): Non-beta-lactam option for penicillin-allergic patients. 5-day course. Watch for local macrolide resistance patterns.

Step 3: Direct Patients to Pharmacies With Stock

Rather than telling patients to "call around," give them a specific recommendation. Use Medfinder to identify a pharmacy with stock, then send the prescription directly there.

If your patient typically uses a chain pharmacy, suggest trying an independent pharmacy as well — they often use different distributors and may have stock when chains don't.

Step 4: Consider Formulation Flexibility

If the suspension is unavailable but tablets are in stock:

• For children who can swallow tablets (typically age 8+), prescribe the 250 mg tablet form
• For younger children, ask the pharmacist about crushing tablets for a compounded suspension — some compounding pharmacies can prepare this
• Switch to an alternative antibiotic that has suspension readily available (Amoxicillin/Clavulanate or Cephalexin suspensions are usually easier to find)

Step 5: Educate Your Patients

Brief patient education can prevent frustration and unnecessary callbacks:

• Let patients know the medication may be harder to find at the first pharmacy they try
• Recommend they check Medfinder before going to the pharmacy
• Explain that if their pharmacy doesn't have it, they should call your office for an alternative rather than waiting days

Alternative Prescribing: Quick Reference

Here's a condition-by-condition alternative guide when Cefprozil is unavailable:

• Acute sinusitis: Amoxicillin/Clavulanate 875/125 mg BID × 5–7 days, or Cefuroxime 500 mg BID × 10 days
• Otitis media (pediatric): Amoxicillin/Clavulanate 45 mg/kg/day (Amoxicillin component) divided BID, or Cefuroxime 30 mg/kg/day divided BID
• Pharyngitis/tonsillitis: Cephalexin 500 mg BID × 10 days, or Amoxicillin 500 mg BID × 10 days
• Acute bronchitis exacerbation: Amoxicillin/Clavulanate 875/125 mg BID × 5–7 days, or Azithromycin 500 mg day 1 then 250 mg days 2–5
• Skin infections: Cephalexin 500 mg QID × 7–10 days

Workflow Tips for Your Practice

To reduce the operational burden of shortage-related disruptions:

1. Create a shortage protocol: Document your preferred Cefprozil alternatives in your EHR as a quick-reference order set. This speeds up the rewrite when a callback comes in.
2. Empower staff: Train your MAs or nurses to check Medfinder for availability and to initiate the prescription change workflow when a pharmacy calls about a shortage.
3. Use e-prescribing flexibility: Send prescriptions to pharmacies confirmed to have stock rather than defaulting to the patient's usual pharmacy.
4. Batch shortage communications: If you see multiple Cefprozil callbacks in a week, consider a proactive approach — temporarily default to Cefuroxime or Amoxicillin/Clavulanate for new prescriptions until supply stabilizes.

Final Thoughts

Drug shortages are an operational reality in 2026, and Cefprozil is one of many medications affected. The providers who navigate these disruptions most effectively are those who check availability proactively, maintain a flexible prescribing approach, and use tools like Medfinder for Providers to direct patients to pharmacies with stock.

For the clinical background on this shortage, see our companion article: Cefprozil shortage — what providers and prescribers need to know in 2026.

For patient-facing resources you can share, see: How to find Cefprozil in stock near you.